Page last updated: 2024-08-26

mci 9038 and Anesthesia

mci 9038 has been researched along with Anesthesia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arai, T; Chiba, A; Okuda, Y; Saima, S; Saito, T; Uchida, E	1
Kanemitsu, S; Nishikawa, M; Onoda, K; Shiku, H; Shimono, T; Shimpo, H; Tanaka, K; Yada, I; Yazaki, A	1
Bauer, C; Kleinschmidt, S; Pindur, G; Stephan, B	1

Reviews

1 review(s) available for mci 9038 and Anesthesia

Article	Year
[Argatroban: pharmacological properties and anaesthesiological aspects]. Der Anaesthesist, 2006, Volume: 55, Issue:4 Topics: Anesthesia; Anticoagulants; Antithrombins; Arginine; Coronary Vessels; Critical Care; Extracorporeal Circulation; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Respiration, Artificial; Sulfonamides; Thrombocytopenia	2006

Other Studies

2 other study(ies) available for mci 9038 and Anesthesia

Article	Year
[Anesthetic management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor]. Masui. The Japanese journal of anesthesiology, 2009, Volume: 58, Issue:9 Topics: Aged; Anesthesia; Angina Pectoris; Anticoagulants; Arginine; Coronary Artery Bypass, Off-Pump; Heparin; Humans; Infusions, Intravenous; Intraoperative Care; Male; Pipecolic Acids; Sulfonamides; Thrombocytopenia	2009
Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation. The Journal of thoracic and cardiovascular surgery, 2003, Volume: 126, Issue:2 Topics: Abciximab; Alprostadil; Anesthesia; Annexin A5; Antibodies, Monoclonal; Anticoagulants; Arginine; Blood Platelets; Dipeptides; Dose-Response Relationship, Drug; Drug Combinations; Dual Specificity Phosphatase 2; Extracorporeal Circulation; Heparin; Humans; Immunoglobulin Fab Fragments; P-Selectin; Pipecolic Acids; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoprotein IIb; Protein Phosphatase 2; Protein Tyrosine Phosphatases; Sulfonamides; Treatment Outcome; von Willebrand Factor	2003

Article

Year

[Anesthetic management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor].

Masui. The Japanese journal of anesthesiology, 2009, Volume: 58, Issue:9

Topics: Aged; Anesthesia; Angina Pectoris; Anticoagulants; Arginine; Coronary Artery Bypass, Off-Pump; Heparin; Humans; Infusions, Intravenous; Intraoperative Care; Male; Pipecolic Acids; Sulfonamides; Thrombocytopenia

2009

Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation.

The Journal of thoracic and cardiovascular surgery, 2003, Volume: 126, Issue:2

Topics: Abciximab; Alprostadil; Anesthesia; Annexin A5; Antibodies, Monoclonal; Anticoagulants; Arginine; Blood Platelets; Dipeptides; Dose-Response Relationship, Drug; Drug Combinations; Dual Specificity Phosphatase 2; Extracorporeal Circulation; Heparin; Humans; Immunoglobulin Fab Fragments; P-Selectin; Pipecolic Acids; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoprotein IIb; Protein Phosphatase 2; Protein Tyrosine Phosphatases; Sulfonamides; Treatment Outcome; von Willebrand Factor

2003